(Q30983330)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15724805%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

review article

1 reference

title

Sex-steroid hormones, gonadotropin and ovarian carcinogenesis: a review of epidemiological and experimental data (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15724805%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15724805%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

S Cosio

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15724805%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

A Gargini

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15724805%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

A R Genazzani

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15724805%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

1 October 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15724805%20AND%20SRC:MED&resulttype=core&format=json

Gynecological Endocrinology

8 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15724805%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15724805%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15724805%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

216-228

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15724805%20AND%20SRC:MED&resulttype=core&format=json

Epidemiology of ovarian cancer: a summary review

8 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

Ovarian cancer: epidemiology, biology, and prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

Survival and prognostic factors in patients with ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

Survival of Californian women with epithelial ovarian cancer, 1994-1996: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

Surgical advances in the treatment of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

Up date in the management of advanced ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

Exploratory phase III study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

Current understanding of the epidemiology and clinical implications of BRCA1 and BRCA2 mutations for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

Prospective study of talc use and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

Cosmetic talc should not be listed as a carcinogen: comments on NTP's deliberations to list talc as a carcinogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

Reproductive Factors and Epithelial Ovarian Cancer Risk by Histologic Type:A Multiethnic Case-Control Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

Parity, age at first childbirth, and risk of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

Fertility therapy in the setting of a history of invasive epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

Ovulation and risk of epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

Reproductive hormones and cancer: ovarian and colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

Oral contraceptives and reproductive system cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

Impact of progestin and estrogen potency in oral contraceptives on ovarian cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy--long-term follow-up of a Swedish cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

Hormone replacement therapy and risk of epithelial ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

Hormone replacement therapy formulations and risk of epithelial ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

Hormone replacement therapy and survival after surgery for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

Hormone replacement therapy in women treated for gynaecological malignancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

Expression and actions of both the follicle stimulating hormone receptor and the luteinizing hormone receptor in normal ovarian surface epithelium and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

Ovarian epithelial tumor growth promotion by follicle-stimulating hormone and inhibition of the effect by luteinizing hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

Expression of receptors for luteinizing hormone-releasing hormone in human ovarian and endometrial cancers: frequency, autoregulation, and correlation with direct antiproliferative activity of luteinizing hormone-releasing hormone analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

Potential role of gonadotrophin-releasing hormone (GnRH)-I and GnRH-II in the ovary and ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

Clinical significance of expression of estrogen receptor alpha and beta mRNAs in ovarian cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

Endometriosis-associated ovarian carcinoma: differential expression of vascular endothelial growth factor and estrogen/progesterone receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

Absence of estrogen receptor-alpha expression in human ovarian clear cell adenocarcinoma compared with ovarian serous, endometrioid, and mucinous adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

Progesterone receptor isoforms A and B in human epithelial ovarian carcinoma: immunohistochemical and RT-PCR studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

Ovarian cancer and polymorphisms in the androgen and progesterone receptor genes: a HuGE review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

Gonadotropin and steroid hormones stimulate proliferation of the rat ovarian surface epithelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

GnRH agonist therapy in human ovarian epithelial carcinoma (OVCAR-3) heterotransplanted in the nude mouse is characterized by latency and transience

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

Role of gonadotropin-releasing hormone (GnRH) in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

Inhibition of human epithelial ovarian cancer cell growth in vitro by agonistic and antagonistic analogues of luteinizing hormone-releasing hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

Cellular mechanisms of growth inhibition of human epithelial ovarian cancer cell line by LH-releasing hormone antagonist Cetrorelix

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

Progestin-induced apoptosis in the Macaque ovarian epithelium: differential regulation of transforming growth factor-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

Progesterone-induced apoptosis in immortalized normal and malignant human ovarian surface epithelial cells involves enhanced expression of FasL

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

Endocrine therapy for gynecological cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

Phase II trial of medroxyprogesterone acetate in advanced ovarian cancer: an EORTC Gynecological Cancer Cooperative Group Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

D-TRP-6-LHRH (Triptorelin) is not effective in ovarian carcinoma: an EORTC Gynaecological Cancer Co-operative Group Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

Phase II study of cetrorelix, a luteinizing hormone-releasing hormone antagonist in patients with platinum-resistant ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

New insights regarding pharmacologic approaches for ovarian cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

Targeted therapy for epithelial ovarian cancer: current status and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

Risk Factors for Invasive Epithelial Ovarian Cancer: Results from a Swedish Case-Control Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

Diet and ovarian cancer risk: A case-control study in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

Influence of menstrual and reproductive factors on ovarian cancer risk in women with and without family history of breast or ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

Use of fertility drugs and risk of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

Long-term effects of oral contraceptives on ovarian cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

Infertility, Fertility Drugs, and Ovarian Cancer: A Pooled Analysis of Case-Control Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

Long-term surveillance of mortality and cancer incidence in women receiving hormone replacemen therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590400014354

10.1080/09513590400014354

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15724805%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference